Beta Bionics, Inc. (NASDAQ:BBNX) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Beta Bionics Second Quarter 2025 Earnings Conference Call.
Beta Bionics Inc. (BBNX)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.00 | 33,350 | $566,950.00 | 59,019 | 2025-01-31 | Filing | |
| $17.00 | 1,000,000 | $17,000,000.00 | 3,901,599 | 2025-01-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.01 | 4,413 | $75,082.78 | 45,503 | 2025-08-22 | Filing | |
| $16.61 | 16,158 | $268,376.30 | 34,132 | 2025-08-19 | Filing | |
| $17.03 | 5,587 | $95,171.75 | 45,503 | 2025-08-19 | Filing | |
| $18.69 | 79 | $1,476.59 | 34,132 | 2025-06-02 | Filing | |
| $18.15 | 551 | $10,000.04 | 34,211 | 2025-06-02 | Filing |
News See All
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas
Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc.
Wolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform Rating
As per the analyst, the insulin pumps are a double-digit growth category, with the company taking share from the low base. The firm believes that Beta Bionics, Inc.
Beta Bionics, Inc. (NASDAQ:BBNX) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Beta Bionics First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
